Test Price
550 AED✅ Home Collection Available
Ki-67 Proliferation Index (IHC) | 550 AED | Dubai
Executive Summary & Core Metrics
- Diagnostic sensitivity exceeding 99.9% via ISO-compliant, digitally augmented IHC processing.
- Secure Medical Courier Solid Tissue Specimen Retrieval for archival FFPE blocks; no mobile phlebotomy.
- Post-report telephonic consultation with a board-certified oncopathologist for result interpretation.
- Insurance direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Ki-67 Proliferation Index (IHC) is an essential biomarker quantifying the fraction of malignant cells actively dividing within a tumor. Performed on formalin-fixed paraffin-embedded (FFPE) tissue, this test provides objective, reproducible prognostic data to guide oncology treatment decisions.
| Parameter | Our Test | Closest Alternative |
|---|---|---|
| Precision / Methodology | Gold‑standard IHC with digital image analysis (MIB‑1 antibody), validated against AI‑assisted pathology consensus | Basic manual visual scoring with higher inter‑observer variability |
| Turnaround Time | 5 working days (FFPE block) or 7 days for large complex resections | 7–10 working days, often without digital quantification |
| Integrated Clinical Report | Includes histopathology correlation and a telephonic consultation with an oncopathologist | Standalone numeric result without interpretive support |
| Regulatory Accreditations | ISO 9001:2015, DHA‑licensed (Facility 1143), compliant with Federal Decree‑Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019 | May not hold all UAE‑specific accreditation layers |
Physician Insight & Safety Protocols
“The Ki-67 index is a critical piece of the oncological puzzle. It must be interpreted alongside full histopathology, receptor status, and imaging. Never alter your treatment plan based solely on a single biomarker. Always consult your managing oncologist before making any changes.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA License: 61713011)
Medication Safety Warning
Do not discontinue, pause, or modify any cancer-directed therapy, hormone treatment, or targeted agent without explicit instruction from your treating physician.
Patient Exclusion Criteria & Emergency Red Flags
- This test uses previously collected FFPE tissue; no new invasive procedure is necessary.
- If you experience bleeding, wound infection, or unusual pain at the original biopsy site, seek immediate medical attention before submitting the specimen.
- Patients under 18 years require guardian consent as mandated by UAE Federal Law.
Patient FAQ & Clinical Guidance
1. What does the Ki-67 test measure and how is it interpreted?
Ki-67 index quantifies the percentage of tumor cells actively proliferating, guiding tumor aggressiveness and treatment likelihood. The result is expressed as a percentage; a high index often correlates with more aggressive disease but must be weighed with other pathological features. Normal tissue shows very low positivity, while certain high-grade malignancies exceed 50–90%.
2. How long does it take to receive Ki-67 test results in Dubai?
Results are typically available within 5 working days using our rapid digital pathology workflow. For large, complex resections the reporting may extend up to 7 days to allow comprehensive analysis. Once finalized, you will receive a secure electronic report with optional telephonic interpretation.
3. Can I use health insurance for this test?
We verify direct billing eligibility with all major UAE insurers via WhatsApp at +971 54 548 8731. Our team checks your policy coverage before the test and handles the reimbursement process. Self‑pay patients can also avail of transparent pricing at 550 AED.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted and handled in accordance with the highest standards of confidentiality. DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | Ki-67 Proliferation Index (IHC) |
| Price (AED) | 550 |
| Turnaround Time | 5–7 working days (depending on specimen complexity) |
| Sample Type / Matrix | Formalin-fixed paraffin-embedded (FFPE) tissue block — Archival Specimen. Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval. |
| Methodology Used | Immunohistochemistry (IHC) with digital image analysis using MIB-1 antibody |
| ICD-10-CM Code | C50.9 (Malignant neoplasm of breast, unspecified) |
| LOINC Code | 44661-2 (Ki-67 antigen [Interpretation] in Tissue) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians